Back to Results
First PageMeta Content
PRC2 / Polycomb-group proteins / EZH2 / Cellular differentiation / Prostate cancer / Methylation / Gene silencing / EED / DNA methylation / Genetics / Biology / Epigenetics


Open Document

File Size: 2,26 MB

Share Result on Facebook

City

Vancouver / /

Company

Living Tumor Laboratory / DrugBank / Creative Commons / /

Country

Canada / /

/

Event

FDA Phase / /

Facility

University of British Columbia / Living Tumor Laboratory / /

IndustryTerm

chemical marks / large network / particular chemical mark / chemical modifications / /

MedicalCondition

genes prostate tumors / PCa tumor / epithelial lung cancer / neuroendocrine prostate cancer / small cell lung cancer / colon cancer / high-grade tumors / aggressive neuroendocrine tumors / SCLC / NEPC tumor / xenograft tumor / each tumor / prostate cancer / lung adenocarcinoma / invariably lethal disease / adenocarcinoma / NEPC patient tumors / tumor / both tumor / squamous cell carcinoma / cancer / lethal disease / tumors / disease / human cancer / neuroendocrine tumor / aggressive tumor / aggressive disease / lung cancer / NEPC (LTL331R) tumor / /

OperatingSystem

L3 / /

Organization

Department of Experimental Therapeutics / Faculty of Medicine / PRC1 / PcG / Living Tumor Lab / PRC1 and PRC2 / FDA / PRC2 / British Columbia Cancer Research Centre / CBX / University of British Columbia / at disrupting altered PcG-mediated silencing / /

Person

Eraser Reader / Gleason Score Taylor Prostate / Gleason Score Setlur Prostate / Gleason Score Lapointe Prostate / Taylor Prostate / Gleason Score Tomlins Prostate / Gleason Score Vanaja Prostate / /

Position

author / Writer / representative / H3K27me3 writer / /

Product

6E-11 / /

ProvinceOrState

British Columbia / Arkansas / /

Technology

antibodies / stem cells / DNA Chip / gene expression / /

URL

http /

SocialTag